News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
304,499 Results
Type
Article (15821)
Company Profile (107)
Press Release (288562)
Multimedia
Podcasts (69)
Webinars (16)
Section
Business (95082)
Career Advice (501)
Deals (16347)
Drug Delivery (81)
Drug Development (43922)
Employer Resources (59)
FDA (7448)
Job Trends (6800)
News (166316)
Policy (15596)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (498)
Accelerated approval (16)
Adcomms (11)
Allergies (77)
Alliances (24193)
ALS (65)
Alzheimer's disease (671)
Antibody-drug conjugate (ADC) (128)
Approvals (7703)
Artificial intelligence (232)
Autoimmune disease (58)
Automation (13)
Bankruptcy (157)
Best Places to Work (4931)
BIOSECURE Act (10)
Biosimilars (125)
Biotechnology (41)
Bladder cancer (77)
Brain cancer (34)
Breast cancer (264)
Cancer (2019)
Cardiovascular disease (187)
Career advice (447)
Career pathing (16)
CAR-T (98)
CDC (6)
Cell therapy (268)
Cervical cancer (15)
Clinical research (39133)
Collaboration (827)
Compensation (395)
Complete response letters (39)
COVID-19 (936)
CRISPR (48)
C-suite (594)
Cystic fibrosis (63)
Data (2677)
Denatured (18)
Depression (77)
Diabetes (188)
Diagnostics (1783)
Digital health (9)
Diversity (3)
Diversity, equity & inclusion (19)
Drug discovery (119)
Drug pricing (119)
Drug shortages (13)
Duchenne muscular dystrophy (109)
Earnings (37731)
Editorial (23)
Employer branding (5)
Employer resources (54)
Events (43406)
Executive appointments (697)
FDA (9015)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (6)
Funding (624)
Gene editing (90)
Generative AI (19)
Gene therapy (239)
GLP-1 (489)
Government (1570)
Grass and pollen (4)
Guidances (201)
Healthcare (4388)
HIV (15)
Huntington's disease (18)
IgA nephropathy (43)
Immunology and inflammation (88)
Immuno-oncology (23)
Indications (65)
Infectious disease (1016)
Inflammatory bowel disease (85)
Inflation Reduction Act (9)
Influenza (29)
Intellectual property (128)
Interviews (63)
IPO (6593)
IRA (33)
Job creations (2098)
Job search strategy (394)
JPM (34)
Kidney cancer (12)
Labor market (32)
Layoffs (245)
Leadership (12)
Legal (3542)
Liver cancer (39)
Longevity (8)
Lung cancer (274)
Lymphoma (197)
Machine learning (16)
Management (21)
Manufacturing (467)
MASH (91)
Medical device (2505)
Medtech (2519)
Mergers & acquisitions (10228)
Metabolic disorders (551)
Multiple sclerosis (63)
NASH (16)
Neurodegenerative disease (127)
Neuropsychiatric disorders (45)
Neuroscience (1234)
Neurotech (1)
NextGen: Class of 2026 (1722)
Non-profit (748)
Now hiring (18)
Obesity (261)
Opinion (166)
Ovarian cancer (76)
Pain (121)
Pancreatic cancer (84)
Parkinson's disease (110)
Partnered (12)
Patents (246)
Patient recruitment (226)
Peanut (19)
People (32313)
Pharmaceutical (64)
Pharmacy benefit managers (19)
Phase 1 (9510)
Phase 2 (16089)
Phase 3 (16198)
Pipeline (2653)
Policy (142)
Postmarket research (1504)
Preclinical (3631)
Press Release (28)
Prostate cancer (121)
Psychedelics (23)
Radiopharmaceuticals (148)
Rare diseases (465)
Real estate (2736)
Recruiting (20)
Regulatory (12720)
Reports (19)
Research institute (658)
Resumes & cover letters (61)
Rett syndrome (23)
RNA editing (6)
RSV (25)
Schizophrenia (88)
Series A (112)
Series B (86)
Service/supplier (2)
Sickle cell disease (51)
Special edition (10)
Spinal muscular atrophy (103)
Sponsored (10)
Startups (1715)
State (2)
Stomach cancer (6)
Supply chain (52)
Tariffs (68)
The Weekly (49)
Vaccines (332)
Venture capital (43)
Weight loss (159)
Women's health (35)
Worklife (4)
Date
Last 7 days (242)
Last 30 days (890)
Last 365 days (13696)
2026 (1295)
2025 (13986)
2024 (15498)
2023 (17151)
2022 (22367)
2021 (23155)
2020 (21527)
2019 (16580)
2018 (13010)
2017 (15297)
2016 (14281)
2015 (16845)
2014 (13267)
2013 (11189)
2012 (11989)
2011 (12492)
2010 (11404)
Location
Africa (331)
Alabama (27)
Alaska (2)
Arizona (85)
Arkansas (3)
Asia (23036)
Australia (3112)
California (4396)
Canada (1727)
China (637)
Colorado (208)
Connecticut (178)
Delaware (150)
Europe (45606)
Florida (733)
Georgia (110)
Hawaii (1)
Idaho (10)
Illinois (410)
India (49)
Indiana (252)
Iowa (6)
Japan (267)
Kansas (82)
Kentucky (22)
Louisiana (6)
Maine (10)
Maryland (497)
Massachusetts (3331)
Michigan (64)
Minnesota (247)
Mississippi (1)
Missouri (52)
Montana (10)
Nebraska (9)
Nevada (23)
New Hampshire (22)
New Jersey (1669)
New Mexico (7)
New York (1282)
North Carolina (744)
North Dakota (3)
Northern California (2165)
Ohio (106)
Oklahoma (6)
Oregon (21)
Pennsylvania (1001)
Puerto Rico (12)
Rhode Island (19)
South America (519)
South Carolina (16)
South Dakota (1)
Southern California (1740)
Tennessee (75)
Texas (587)
United States (16595)
Utah (108)
Virginia (168)
Washington D.C. (43)
Washington State (292)
West Virginia (3)
Wisconsin (55)
Wyoming (2)
304,499 Results for "pivot pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Regulatory
FDA’s ‘Conundrum’: What To Do With Approved Drugs That Fail Pivotal or Confirmatory Trials
With notable therapies from Biogen, Sarepta and MacroGenics failing to show efficacy in pivotal or confirmatory trials, experts question the use of biomarker evidence for approval while one former regulator insists that a “failed trial is not a failed drug.”
December 15, 2025
·
7 min read
·
Heather McKenzie
Insights
From Awareness to Acceleration: Rare Disease Drug Development Enters a Pivotal Era
Investor enthusiasm and evolving FDA pathways are accelerating rare disease drug development, with ultrarare conditions like MPS II moving into the spotlight.
February 4, 2026
·
3 min read
·
Jennifer Smith-Parker
Press Releases
Jupiter Endovascular Announces Completion of Enrollment in SPIRARE II Pivotal Trial
February 5, 2026
·
4 min read
Press Releases
Alvotech Announces Positive Top-Line Results from Pivotal Pharmacokinetic Study for Proposed Biosimilar to Entyvio®
February 5, 2026
·
6 min read
Press Releases
Modular Medical Achieves Key Manufacturing Milestone for Pivot Tubeless Insulin Patch Pump
February 5, 2026
·
4 min read
Press Releases
IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
February 5, 2026
·
8 min read
Press Releases
EyePoint Reports Corporate Update and Anticipated Pivotal Milestones for 2026
January 7, 2026
·
13 min read
Layoffs
InflaRx Stanches Spending With 30% Staff Reduction, Priority Pivot
Aside from the layoffs, InflaRx will deprioritize Gohibic, a COVID-19 antibody that was granted emergency use authorization in 2023. The therapy failed a late-stage trial in a rare skin disease last year.
January 9, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Salarius Pharmaceuticals Announces Planned Corporate Name and Ticker Symbol Change to Decoy Therapeutics, Reflecting Strategic Pivot to Next-Generation Antiviral and Peptide-Conjugate Platform
December 19, 2025
·
6 min read
Press Releases
IntraBio Announces Positive Pivotal Trial Results of Levacetylleucine for the Treatment of Ataxia-Telangiectasia
January 21, 2026
·
5 min read
1 of 30,450
Next
